These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33108675)

  • 1. ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas.
    Puvaneswaralingam S; Kjellbom A; Lindgren O; Löndahl M; Olsen H
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):168-175. PubMed ID: 33108675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed ACTH Is Frequently Unrelated to Autonomous Cortisol Secretion in Patients With Adrenal Incidentalomas.
    Olsen H; Kjellbom A; Löndahl M; Lindgren O
    J Clin Endocrinol Metab; 2019 Feb; 104(2):506-512. PubMed ID: 30265354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study.
    Bonaventura I; Tomaselli A; Angelini F; Ferrari D; De Alcubierre D; Hasenmajer V; Sbardella E; Cozzolino A; Paganini AM; Isidori AM; Minnetti M; Pofi R
    J Endocrinol Invest; 2024 Jul; 47(7):1751-1762. PubMed ID: 38386266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroidogenesis in patients with adrenal incidentalomas: Extended steroid profile measured by liquid chromatography-mass spectrometry after ACTH stimulation and dexamethasone suppression.
    Huayllas MKP; Smith LM; Gallagher JC; Netzel BC; Singh RJ; Kater CE
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):29-40. PubMed ID: 33598999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
    Suliman AM; Smith TP; Labib M; Fiad TM; McKenna TJ
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma.
    Eller-Vainicher C; Morelli V; Salcuni AS; Battista C; Torlontano M; Coletti F; Iorio L; Cairoli E; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A; Chiodini I
    Eur J Endocrinol; 2010 Dec; 163(6):925-35. PubMed ID: 20881060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors.
    Zhu H; Wu L; Su T; Jiang L; Zhou W; Jiang Y; Zhang C; Zhong X; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1199875. PubMed ID: 37560307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C; Hesse S; Stoppe M; Meyer K; Schmidt E; Orthgiess J; Bechmann L; Bresch A; Rullmann M; Luthardt J; Sabri O; Blüher M; Kratzsch J; Then Bergh F
    Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
    Merz U; Pfäffle R; Peschgens T; Hörnchen H
    Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.